OVPR Chief of Staff Selected As One of St. Louis Business Journal's Top 40 Under 40
10/27/2023
Jasmin Patel, Associate Vice President for Research and Chief of Staff to the Vice President for Research and Partnerships at St. Louis University, has been named a St. Louis Business Journal 40 Under 40 for 2023.
Patel has been with SLU since 2016. She was selected from a field of more than 350 nominations.
Jasmin Patel, Associate Vice President for Research and Chief of Staff to the Vice President for Research and Partnerships at St. Louis University. Photo by Sarah Conroy.
“It’s an honor to be nominated and selected – it was quite a surprise,” Patel said. “It is also a responsibility to continue to work hard to make an impact and to support and mentor others.
The annual list, which will be published in the Nov. 3 issue of the Business Journal, recognizes 40 emerging St. Louis-area business leaders under the age of 40 who are highly engaged with the St. Louis community. Patel and her cohort will be recognized at the 40 Under 40 celebration at 5 p.m. on Thursday, Nov. 2, at the Marriott St. Louis Grand.
Born in Manchester in the United Kingdom, Patel earned her bachelor of science degree in Speech and Hearing Science from the University of Illinois, Urbana-Champaign. She then earned her MBA from the University of Chicago.
At Chicago, Patel worked as a Clinical Research Associate, the Executive Director at Arete: A Research Accelerator, and was Chief of Staff for the Research Computing Center.
From there, she joined Saint Louis University first as Assistant Vice President of Research Strategy and Innovation.
“I came to SLU because of the amazing research already happening here and the potential for growth,” Patel said.
In July 2022, she was promoted to Associate Vice President for Research and Chief of Staff.
“In my current role, I oversee the research operations, strategy, and growth components of the Office of the Vice President for Research,” Patel said. “As Chief of Staff, I also oversee the implementation of our five-year plan for research growth.”
Patel said she’s found a home at SLU.
“I really like the ways in which the Jesuit mission can have an impact on everyone here, regardless of your own background or beliefs,” she said. “I think that this creates a community that comes together for each other in times of need, and this is something I have seen time and time again at SLU.”
She said she enjoys working with the OVPR team, which is made up of “an incredible group of individuals.”
Latest Newslink
- Robert I. Bolla, Ph.D.: 1943-2025Robert I. Bolla, Ph.D., former chair of the Department of Biology at Saint Louis University, died Sunday, July 27, 2025. He was 81. Bolla worked at SLU from 1989 to 2001.
- SLU Welcomes 175 New Medical Students at White Coat CeremonySaint Louis University’s School of Medicine marked a pivotal milestone for 175 incoming medical students at its annual White Coat Ceremony. On Sunday, July 27, faculty, family, and friends convened at St. Francis Xavier College Church to honor the students' achievements and their forthcoming pledge to the medical profession.
- Saint Louis University Hosts National Jesuit Student Leadership ConferenceSaint Louis University hosted student government leaders from Jesuit colleges and universities on campus July 22-26. This was the first time SLU hosted the National Jesuit Student Leadership Conference.
- James Hitchcock, Ph.D.: 1938-2025James F. Hitchcock, Ph.D., professor emeritus of history, died Monday, July 14, 2025. He was 87. Hitchcock authored several books on the history of the Catholic Church.
- Lentine Receives Award of Merit for Outstanding Contributions to Scientific MedicineKrista Lentine, M.D., Ph.D., professor of medicine at Saint Louis University's School of Medicine, is the 2024 recipient of the St. Louis Metropolitan Medicine Society Award of Merit for Outstanding Contributions to Scientific Medicine.
- We Should Treat More People with Hepatitis B, SLU Expert SaysIn a pair of articles published in Lancet Gastroenterology and Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B.
